|
Nov 1
|
Jasper Therapeutics Announces Appointment of Thomas G. Wiggans as Chairperson of the Board of Directors
|
|
Oct 31
|
Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023
|
|
Sep 11
|
Journey Medical Gains 40%, Insider Trades Reap Benefit
|
|
Sep 9
|
Insider Buying: Journey Medical Corp's President & CEO Claude Maraoui Acquires 26,044 Shares
|
|
Sep 7
|
Journey Medical (DERM) & Maruho Ink Deal for Qbrexza Asia Rights
|
|
Sep 6
|
Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations
|
|
Jul 19
|
Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023
|
|
May 22
|
Journey Medical Corporation (DERM) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 22
|
Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
|
|
May 19
|
Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023
|